Skip to main content

Table 1 Numbers and proportions (%) of patients with seropositive rheumatoid arthritis (RA), seronegative RA and undifferentiated arthritis using various anti-rheumatic drugs and drug combination strategies by the end of the first month after arthritis diagnosis

From: First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study

 

Seropositive rheumatoid arthritis

N = 4998

Seronegative rheumatoid arthritis

N = 2340

Undifferentiated arthritis

N = 2433

p-value

Females N (%)

3349 (67.0)

1584 (67.7)

1650 (67.8)

 

Mean age at diagnosis, years (SD)

58 (15)

56 (17)

49 (17)

 

Combination strategies of DMARDs, N(%)

 Two DMARDs

1684 (33.7)

727 (31.1)

395 (16.2)

< 0.001

 Three DMARDs

1118 (22.4)

255 (10.9)

77 (3.1)

< 0.001

 MTX-based combination

2489 (49.8)

841 (35.9)

390 (16.0)

< 0.001

 FIN-RACo combination*

1114 (22.3)

253 (10.8)

75 (3.1)

< 0.001

  MTX + SSZ + HCQ + PRD

922 (18.4)

205 (8.8)

52 (2.1)

 

  MTX + SSZ + HCQ

192 (3.8)

48 (2.1)

23 (0.9)

 

Medications

 Methotrexate (MTX)

3602 (72.1)

1483 (63.4)

1043 (42.9)

< 0.001

  MTX per os

3428 (68.6)

1399 (59.8)

949 (39.0)

 

  MTX s.c.

174 (3.5)

84 (3.6)

94 (3.9)

 

 Sulfasalazine (SSZ)

2059 (41.2)

880 (37.6)

1121 (46.1)

< 0.001

 Hydroxychloroquine (HCQ)

2272 (55.5)

940 (40.2)

472 (19.4)

< 0.001

 Leflunomide

51 (1.0)

30 (1.3)

23 (1)

0.48

 Azathioprine

29 (0.6)

11 (0.5)

14 (0.6)

0.83

 Aurathiomalate

9 (0.2)

2 (0.1)

2 (0.1)

0.44

 Auranofin

3 (0.1)

1 (0.0)

1 (0.0)

0.95

 Cyclosporine

1 (0.0)

3 (0.1)

6 (0.3)

0.015

 Prednisolone (PRD)

3025 (60.5)

1352 (57.8)

890 (36.6)

< 0.001

 Self-injected biologics (all)

41 (0.8)

28 (1.2)

17 (0.7)

0.15

 Etanercept

3 (0.06)

11 (0.47)

2 (0.08)

 

 Adalimumab

4 (0.08)

6 (0.27)

1 (0.04)

 

 Certolizumab

1 (0.02)

0 (0)

0 (0)

 

 Golimumab

3 (0.03)

1 (0.04)

0 (0)

 

 Abatacept

1 (0.02)

0 (0)

0 (0)

 

 No antirheumatic medication

401 (8.0)

227 (9.7)

300 (13.3)

< 0.001

 Only prednisolone

85 (1.7)

63 (2.7)

46 (1.9)

0.61

  1. *FIN-RACo combination: Methotrexate (MTX), sulfasalazine (SSZ), and hydroxychloroquine (HCQ) often combined with low-dose prednisolone (PRD)